News

A team of researchers at Cornell University has made a discovery in fruit flies that could change the way we understand brain ...
China has retaliated against the latest round of U.S. tariffs with higher duties on American exports, putting at stake a whopping $650 billion in trade between the two largest economies in the ...
Micro decisions can have macro consequences. A soft matter physicist reveals how interactions within simple cellular ...
The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus immune checkpoint inhibitors. The first patient with small cell lung cancer ...
The innovation relates to how cell drive strength should be determined. 2. 1X Dominant Drive Problem Historically, regardless of the speed and power targets of an ASIC implementation, the 1X drive has ...
There are few things more frustrating than experiencing a poor signal on your cell phone. From dropped calls to messages that won’t send and streaming services that stutter and die, a lack of ...
Using the best PvE weapons makes beating Destiny 2’s most challenging content much easier. To help you overcome what lies ahead, you’ll want to be using these recommended meta guns in Episode ...
(2) Using gene expression data as input cannot directly establish the relationship between cell types and TCNs in a tissue, making the interpretation of TCNs challenging. (3) Given a cohort of tissue ...
meaning Vitaly will be waiting 2-3 years before his trial. On top of this, he’ll be stuck in a shared cell with multiple inmates with no air conditioning with temperatures averaging at 97 degrees.
AZD5335 is currently in a phase 2 trial for ovarian cancer and lung adenocarcinoma ... One of the latest trends in Big Pharma dealmaking is T-cell engagers, and here AstraZeneca has had something ...
Image: Midsummer. Swedish thin-film solar cell company Midsummer has been awarded €2.8 million (US$3 million) by the Italian government to research tandem perovskite cell technology. The Italian ...